E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

Name of the Condition

• Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism.

Summary

This category encompasses a group of inherited metabolic disorders affecting the body's ability to process branched-chain amino acids (BCAAs) and fatty acids. Disruptions in these pathways can lead to the accumulation of toxic byproducts, potentially causing neurological, hepatic, or systemic complications if untreated. The conditions are typically genetic and may present with variable clinical severity.

Causes

These disorders are caused by genetic mutations affecting enzymes or transporters involved in the breakdown or utilization of branched-chain amino acids or fatty acids. Inheritance patterns vary but often include autosomal recessive transmission, where both parents carry a mutated gene. Specific genetic defects determine the affected metabolic pathway and clinical presentation.

Risk Factors

• Family history of metabolic disorders.
• Consanguinity (parents who are closely related).
• Certain ethnic or geographic populations with higher carrier rates for specific mutations.

Symptoms

• Developmental delay or regression.
• Lethargy or poor feeding in infants.
• Vomiting or poor weight gain.
• Neurological symptoms, such as seizures or abnormal muscle tone.
• Metabolic crises, including ketoacidosis or hyperammonemia, in severe cases.
• Hepatomegaly or liver dysfunction in fatty-acid metabolism disorders.

Diagnosis

Diagnosis involves biochemical testing to measure amino acid or fatty acid levels in blood or urine, often supplemented by genetic testing to identify specific mutations. Newborn screening may detect some conditions, while targeted testing is used for symptomatic individuals. Enzyme activity assays or metabolic profiling may further clarify the underlying defect.

Treatment Options

Treatment focuses on managing metabolic crises and preventing complications. This may include dietary modifications (e.g., restricted BCAA or fatty acid intake), supplementation with essential nutrients, and medications to support metabolic pathways. In severe cases, liver transplantation or enzyme replacement therapy may be considered.

Prognosis and Follow-Up

Prognosis varies widely depending on the specific disorder, timing of diagnosis, and adherence to treatment. Early intervention can improve outcomes, but some conditions may lead to progressive neurological damage or organ failure. Regular monitoring of metabolic status, growth, and organ function is essential for long-term management.

Complications

• Neurological impairment (e.g., intellectual disability, seizures).
• Hepatic or cardiac dysfunction.
• Metabolic decompensation during illness or stress.
• Growth failure or developmental delays.

Lifestyle & Prevention

• Adherence to prescribed dietary restrictions and supplements.
• Avoidance of fasting or prolonged periods without food, which can trigger metabolic crises.
• Genetic counseling for families with a history of these disorders.
• Prompt treatment of infections or illnesses to prevent metabolic stress.

When to Seek Professional Help

Seek immediate medical attention for symptoms of metabolic crisis, such as lethargy, vomiting, seizures, or altered consciousness. Routine follow-up with a metabolic specialist is recommended for ongoing management and monitoring.

Tips for Medical Coders

Use code E71 for disorders of branched-chain amino-acid metabolism and fatty-acid metabolism when documentation specifies a condition within this category but does not provide further subclassification. Ensure clinical notes support the diagnosis, as coding requires specificity when available. Document any relevant family history or genetic testing results to justify the code selection.